Cancers,
Journal Year:
2024,
Volume and Issue:
16(23), P. 3995 - 3995
Published: Nov. 28, 2024
Introduction:
Prostate
cancer
is
the
second
most
prevalent
among
elderly
males
in
Western
countries.
TRUS
biopsy
remains
a
standard
diagnosing
approach
for
prostate
but
poses
notable
risks,
particularly
older
men,
including
complications
such
as
sepsis,
acute
retention,
and
rectal
bleeding,
which
can
lead
to
substantial
morbidity
mortality.
This
study
aimed
evaluate
cancer-specific
survival
outcomes
men
aged
over
80
years
whether
there
any
advantage
procedure.
Methods:
Between
January
2005
December
2015,
we
studied
of
200
patients
(median
age,
82
years)
with
elevated
prostate-specific
antigen
(PSA)
levels
(>4.0
ng/mL)
and/or
abnormal
digital
examination
(DRE)
who
underwent
biopsy.
Each
participant
was
followed
up
until
death
using
an
electronic
system
unique
identifier
defined
geographical
area.
Cancer-specific
overall
analyses
were
carried
out
utilising
SPSS,
while
R
Project
employed
construct
two
nomograms
duration
predict
risk
post-biopsy.
All
statistical
tests
two-tailed,
significance
set
at
p
<
0.05.
Results:
Amongst
participants,
only
24
alive
end
follow-up
91
years).
The
PSA
ranged
from
4.88
102.7
ng/mL.
Log-rank
Breslow
indicated
that
higher
levels,
development
metastases,
ISUP
grade
group
8–10
associated
shorter
times.
Age,
co-morbid
conditions,
tumour
type
incorporated
into
nomogram
due
their
clinical
significance.
Patients
<81
had
lower
mortality
risk,
those
>88
faced
risks.
Complications
increased
risks
both
cancerous
benign
cases,
metastasis
significantly
heightened
likelihood
death.
However,
conditions
did
not
influence
probability.
Conclusions:
Our
findings
underscore
age
(specifically
above),
high
Gleason
score,
metastasis,
are
predictive
poorer
following
Frontiers in Oncology,
Journal Year:
2024,
Volume and Issue:
14
Published: March 14, 2024
Purpose
Patients
with
advanced
prostate
cancer
(PCa)
often
develop
castration-resistant
PCa
(CRPC)
poor
prognosis.
Prognostic
information
obtained
from
multiparametric
magnetic
resonance
imaging
(mpMRI)
and
histopathology
specimens
can
be
effectively
utilized
through
artificial
intelligence
(AI)
techniques.
The
objective
of
this
study
is
to
construct
an
AI-based
CRPC
progress
prediction
model
by
integrating
multimodal
data.
Methods
materials
Data
399
patients
diagnosed
at
three
medical
centers
between
January
2018
2021
were
collected
retrospectively.
We
delineated
regions
interest
(ROIs)
3
MRI
sequences
viz,
T2WI,
DWI,
ADC
a
cropping
tool
extract
the
largest
section
each
ROI.
selected
representative
pathological
hematoxylin
eosin
(H&E)
slides
for
deep-learning
training.
A
joint
combined
nomogram
was
constructed.
ROC
curves
calibration
plotted
assess
predictive
performance
goodness
fit
model.
generated
decision
curve
analysis
(DCA)
Kaplan–Meier
(KM)
survival
evaluate
clinical
net
benefit
its
association
progression-free
(PFS).
Results
AUC
machine
learning
(ML)
0.755.
best
deep
(DL)
radiomics
pathomics
ResNet-50
model,
0.768
0.752,
respectively.
graph
showed
that
DL
contributed
most,
0.86.
DCA
indicate
had
good
ability
benefit.
KM
indicated
data
guide
patient
prognosis
management
strategies.
Conclusion
integration
improves
risk
progression
CRPC.
Research and Reports in Urology,
Journal Year:
2025,
Volume and Issue:
Volume 17, P. 49 - 57
Published: Feb. 1, 2025
Magnetic
resonance
imaging
(MRI)
is
an
essential
tool
in
Prostate
Cancer
(PCa)
diagnosis.
PI-RADS
v2.1
score
correlates
with
clinically
significant
prostate
cancer
(CSPCa)
and
according
to
the
most
recent
guidelines,
prevalence
of
CSPCa
4
33-41%,
while
5
62-79%.
These
groups
are
separated
only
by
a
size
15
mm
yet
difference
risk
significant.
This
study
aims
find
threshold
associated
within
group,
which
may
be
used
combination
other
prostatic
parameters,
such
as
PSA
density
order
help
stratification
patient
counselling
pre-biopsy
setting.
also
aid
surveillance
smaller
lesions
setting
negative
biopsy
avoid
unnecessary
repeat
biopsies
unless
triggered
threshold.
A
retrospective
was
performed
data
from
407
patients
undergoing
transperineal
(TPPB)
between
April
2022
November
2023.
subgroup
included
for
analysis.
ROC-AUC
obtained.
Median
age
67
(interquartile
range:
61-71)
0.20
range
0.13-0.28).
correlated
CSPCa:
1
2,
frequency
10%;
3,
it
20%;
4,
60%;
5,
80%,
Pearson
correlation
=
0.51,
p
<
0.001.
The
Receiver
Operating
Characteristic
Area
Under
Curve
(ROC-AUC)
determined
0.664
[0.579-0.7499].
optimal
cut-off
point
8.5
mm.
Patients
larger
than
had
2.31
times
higher
CSPCa.
does
matter
useful
predictor
In
our
study,
identified.
provides
specificity
80%
detection.
Frontiers in Oncology,
Journal Year:
2025,
Volume and Issue:
15
Published: April 8, 2025
This
study
aimed
to
establish
and
evaluate
a
model
utilizing
bi-parametric
ultrasound-based
deep
learning
radiomics
(DLR)
in
conjunction
with
clinical
factors
anticipate
clinically
significant
prostate
cancer
(csPCa).
We
retrospectively
analyzed
232
participants
from
our
institution
who
underwent
both
B-mode
ultrasound
shear
wave
elastography
(SWE)
prior
biopsy
between
June
2022
December
2023.
A
random
allocation
placed
the
into
training
test
cohorts
7:3
distribution.
developed
nomogram
that
integrates
DLR
within
cohort,
which
was
subsequently
validated
using
cohort.
The
diagnostic
performance
applicability
were
evaluated
receiver
operating
characteristic
(ROC)
curve
analysis
decision
analysis.
In
study,
demonstrated
an
area
under
(AUC)
of
0.80
(95%CI:
0.70-0.91)
set,
surpassing
models
individually.
By
integrating
factors,
composite
model,
presented
as
nomogram,
exhibited
superior
performance,
achieving
AUC
0.87
0.77-0.95)
set.
exceeded
(P
=
0.049)
(AUC
0.79,
95%CI:
0.69-0.86,
P
0.041).
Furthermore,
indicated
provided
greater
net
benefit
across
various
high-risk
threshold
than
or
alone.
To
knowledge,
this
is
first
proposal
indicators
for
predicting
csPCa.
can
improve
accuracy
csPCa
prediction
may
help
physicians
make
more
confident
decisions
regarding
interventions,
particularly
settings
where
MRI
unavailable.
Diagnostics,
Journal Year:
2025,
Volume and Issue:
15(8), P. 987 - 987
Published: April 13, 2025
Background/Objectives:
Prostate-specific
antigen
(PSA)
persistence,
defined
as
a
postoperative
PSA
level
≥
0.1
ng/mL
measured
within
4-8
weeks
after
radical
prostatectomy
(RP),
predicts
biochemical
recurrence
(BCR)
and
adverse
oncological
outcomes.
The
influence
of
nerve-sparing
(NS)
surgical
techniques
on
persistence
remains
debated,
especially
among
patients
with
high-risk
pathological
features.
This
study
aimed
to
evaluate
the
impact
NS
following
robot-assisted
(RARP),
considering
tumor
characteristics,
parameters,
patient-specific
factors.
Methods:
A
retrospective
cohort
analysis
was
performed
779
who
underwent
RARP
at
single
institution
between
January
2002
December
2015.
inclusion
criteria
consisted
histologically
confirmed
prostate
cancer
available
preoperative
data,
including
measurements
taken
surgery.
served
primary
outcome.
Statistical
analyses
included
descriptive
statistics,
univariate
multivariable
logistic
regression
models
identify
predictors
Spearman's
correlation
along
Kruskal-Wallis
H
test
associations.
Results:
Of
included,
55%
surgery
(51%
unilateral,
49%
bilateral).
mean
11.85
(SD:
7.63),
while
0.70
4.42).
An
elevated
associated
larger
size
(r
=
0.1285,
p
<
0.001),
advanced
stages
(χ2
45.10,
3.79
×
10-9),
higher
Gleason
scores
24.74,
1.57
10-4).
correlated
lower
(mean:
0.20
ng/mL)
compared
non-NS
procedures
0.65
ng/mL),
slight
differences
unilateral
0.30
bilateral
0.35
approaches.
Multivariable
identified
stage
(coefficient
1.16,
0.04)
an
independent
predictor
had
no
significant
effect
-0.01,
0.99).
Conclusions:
Nerve-sparing
do
not
independently
predict
when
adjusting
for
tumor-related
factors
confounders.
Advanced
stage,
particularly
pT3b,
primarily
determines
persistence.
These
findings
highlight
necessity
personalized
planning
informed
by
imaging
patient-centered
decision
making
optimize
functional
Frontiers in Oncology,
Journal Year:
2025,
Volume and Issue:
15
Published: May 5, 2025
The
study
aimed
to
develop
and
externally
validate
multiparametric
MRI
(mpMRI)
radiomics-based
interpretable
machine
learning
(ML)
model
for
preoperative
differentiating
between
benign
malignant
prostate
masses.
Patients
who
underwent
mpMRI
with
suspected
masses
were
retrospectively
recruited
from
two
independent
hospitals
May
2016
2023.
mass
regions
in
T2-weighted
imaging
(T2WI)
diffusion-weighted
(DWI)
images
segmented
by
ITK-SNAP.
PyRadiomics
was
utilized
extract
radiomic
features.
Inter-
intraobserver
correlation
analysis,
t-test,
Spearman
the
least
absolute
shrinkage
selection
operator
(LASSO)
algorithm
a
five-fold
cross-validation
applied
feature
selection.
Five
ML
models
built
using
chosen
Model
performance
evaluated
internal
external
validation,
area
under
curve
(AUC),
calibration
curves,
decision
analysis
select
optimal
model.
interpretability
of
most
robust
conducted
via
SHapley
Additive
exPlanation
(SHAP).
A
total
567
patients
enrolled,
consisting
training
(n
=
352),
test
152),
63)
sets.
In
total,
2,632
features
extracted
interest
(ROIs)
T2WI
DWI
images,
which
reduced
18
LASSO.
established,
among
random
forest
(RF)
presented
best
predictive
ability,
AUCs
0.929
(95%
confidential
interval
[CI]:
0.885-0.963)
0.852
CI:
0.758-0.934)
sets,
respectively.
analyses
confirmed
excellent
clinical
usefulness
RF
Besides,
contributing
relations
uncovered
SHAP.
Radiomic
combined
facilitate
accurate
evaluation
malignancy
SHAP
can
disclose
underlying
prediction
process
model,
may
promote
its
applications.
The Prostate,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Dec. 23, 2024
ABSTRACT
Background
This
study
aims
to
assess
the
relationship
between
body
mass
index
(BMI)
and
prostate
volume,
utilizing
pre
postoperative
measurements.
Methods
A
retrospective,
observational
was
conducted
at
a
single
site
using
data
from
an
institutional
database.
Medical
records
of
patients
who
underwent
robot‐assisted
radical
prostatectomy
were
reviewed.
Data
included
age,
BMI,
volumes
measured
through
digital
rectal
exam
(DRE),
transrectal
ultrasound
(TRUS),
magnetic
resonance
imaging
(MRI),
surgical
specimen
weight
(SPW).
Results
total
168
identified
in
analysis.
Spearman's
correlation
test
revealed
significant
association
BMI
volume
for
all
measurement
methods,
reporting
r
=
0.146
(
p
0.047)
DRE,
0.268
<
0.0001)
TRUS,
0.177
0.021)
MRI
0.234
0.002)
SPW.
Linear
regression
analysis
confirmed
reporting,
respectively,
R
2
0.026
0.036)
0.076
0.038
0.011)
0.040
0.009)
Notably,
considering
SPW
best
way
estimate
every
increase
predicted
is
0.865gr.
Conclusions
demonstrates
positive
linear
highlighting
importance
assessments.
Frontiers in Bioscience-Elite,
Journal Year:
2023,
Volume and Issue:
15(3)
Published: Sept. 20, 2023
Prostate
cancer
ranks
as
the
second
most
frequently
diagnosed
globally
among
men
and
stands
fifth
leading
cause
of
cancer-related
death
in
males.
Hence,
an
early
precise
diagnosis
staging
are
critical.
Traditional
is
based
on
clinical
nomograms
but
presents
a
lower
performance
than
prostate
multiparametric
magnetic
resonance
imaging
(mpMRI).
Since
tumor
serves
basis
for
risk
stratification,
prognosis,
treatment
decision-making,
primary
objective
mpMRI
to
distinguish
between
organ-confined
locally
advanced
diseases.
Therefore,
this
modality
has
emerged
optimal
selection
local
cancer,
offering
incremental
value
evaluating
pelvic
nodal
disease
bone
involvement,
supplying
supplementary
insights
regarding
location
extension.
As
per
Imaging
Reporting
&
Data
System
v2.1
guideline,
comprehensive
accurate
requires
several
key
sequences,
which
include
T1-weighted
(T1WI)
T2-weighted
(T2WI)
morphological
assessment,
with
T2WI
serving
cornerstone
staging.
Additionally,
diffusion-weighted
(DWI)
dynamic
sequences
acquired
intravenous
administration
paramagnetic
contrast
medium
(DCE)
crucial
components.
It
worth
noting
that
while
MRI
exhibits
high
specificity,
its
sensitivity
diagnosing
extracapsular
extension,
seminal
vesicle
invasion,
lymph
node
metastases
limited.
Moreover,
own
constraints
not
effective
detecting
distant
or
nodes,
extended
dissection
remains
gold
standard.
This
review
aims
highlight
significance
provide
practical
approach
assessing
invasions,
involvement
adjacent
organs
nodes.
Cancers,
Journal Year:
2023,
Volume and Issue:
15(21), P. 5296 - 5296
Published: Nov. 5, 2023
Objectives:
This
study
aimed
to
assess
the
impact
of
covariates
derived
from
a
predictive
model
for
detecting
extracapsular
extension
on
pathology
(pECE+)
biochemical
recurrence-free
survival
(BCRFS)
within
4
years
after
robotic-assisted
radical
prostatectomy
(RARP).
Methods:
Retrospective
data
analysis
was
conducted
single
center
between
2015
and
2022.
Variables
under
consideration
included
prostate-specific
antigen
(PSA)
levels,
patient
age,
prostate
volume,
MRI
semantic
features,
Grade
Group
(GG).
We
also
assessed
influence
pECE+
positive
surgical
margins
BCRFS.
To
attain
these
goals,
we
used
Kaplan–Meier
function
multivariable
Cox
regression
model.
Additionally,
analyzed
features
BCR
(biochemical
recurrence)
in
low/intermediate
risk
patients.
Results:
A
total
177
participants
with
follow-up
exceeding
6
months
post-RARP
were
included.
The
1-year,
2-year,
4-year
risks
5%,
13%,
21%,
respectively.
non-parametric
approach
showed
that
adverse
such
as
macroscopic
ECE
(mECE+),
capsular
disruption,
high
tumor
contact
length
(TCCL),
GG
≥
4,
(PSM),
factors
BCR.
In
low/intermediate-risk
patients
(pECE−
<
4),
presence
has
been
shown
increase
Conclusions:
highlights
importance
incorporating
pre-surgery
influencing
early
outcomes
clinical
decision
making;
mECE+,
TCCL,
based
pre-surgical
biopsy
independent
prognostic
can
assist
identifying
who
will
benefit
closer
monitoring.